Literature DB >> 33202152

Positive Role of Chinese Herbal Medicine in Cancer Immune Regulation.

Sumei Wang1,2, Shunqin Long1,2, Zhiyin Deng3, Wanyin Wu1,2.   

Abstract

Complementary and alternative medicine (CAM) plays a critical role in treating cancer patients. Traditional Chinese Medicine (TCM) is the main component of CAM. TCM, especially Chinese Herbal Medicine (CHM), has been increasingly used in China, some other Asian countries and European countries. It has been proven to enhance the efficacy of chemotherapy, radiotherapy, targeted-therapy, and immunotherapy. It lessens the damage caused by these therapies. CHM functions on cancer by inhibiting tumor progression and improving an organism's immune system. Increasing evidence has shown that many CHM exert favorable effects on the immune regulation. We will summarize the role of CHM on patient's immune system when treating cancer patients. Our evidence reveals that single herbs, including their extracts, compound formulations, and preparations, will provide current advances on CHM study, especially from the perspective of immune regulation and novel insights for CHM application in clinic. The main herbs used to treat cancer patients are health-strengthening (Fu-Zheng) herbs and pathogen eliminating (Qu-Xie) herbs. The key mechanism is regulating the immune system of cancer patients. Firstly, health-strengthening herbs are mainly functioned as immune regulatory effectors on cancer. Secondly, some of the compound formulations mainly strengthen the health of patients by regulating the immune system of cancer patients. Lastly, some Chinese medicine preparations are widely used to treat cancer for their properties of spiriting vital energy and anti-cancer effects, mainly by improving immunity. CHM plays a positive role in regulating patients' immune system, which helps cancer patients to fight against cancer itself and finally improves patients' life quality.

Entities:  

Keywords:  Cancer; Chinese Herbal Medicine; Immune; Microenvironment; Review; Traditional Chinese Medicine

Mesh:

Substances:

Year:  2020        PMID: 33202152     DOI: 10.1142/S0192415X20500780

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  22 in total

1.  Network Pharmacology and in vitro Experimental Verification on Intervention of Quercetin, Present in Chinese Medicine Yishen Qutong Granules, on Esophageal Cancer.

Authors:  Jie Li; Jin-Yuan Chang; Zheng-Long Jiang; Yu-Kun Yin; Jia-Yang Chen; Wei Jin; Hao Li; Li Feng
Journal:  Chin J Integr Med       Date:  2022-09-12       Impact factor: 2.626

2.  Protective Effects and Mechanisms of Yinchen Linggui Zhugan Decoction in HFD-Induced Nonalcoholic Fatty Liver Disease Rats Based on Network Pharmacology and Experimental Verification.

Authors:  Hui Jiang; Tangyou Mao; Yuyue Liu; Xiang Tan; Zhongmei Sun; Yuan Cheng; Xiao Han; Yang Zhang; Jiali Wang; Lei Shi; Yi Guo; Junxiang Li; Haixiao Han
Journal:  Front Pharmacol       Date:  2022-06-02       Impact factor: 5.988

3.  Chinese Herbal Prescription Fu-Zheng-Qu-Xie Prevents Recurrence and Metastasis of Postoperative Early-Stage Lung Adenocarcinoma: A Prospective Cohort Study Followed with Potential Mechanism Exploration.

Authors:  Sufang Zhang; Wanqing Chen; Yuli Wang; Jianchun Wu; Lili Xu; Yongchun Yu; Jianhui Tian; Rongzhong Xu; Zhihong Fang; Lei Jiang; Yingbin Luo; Yan Li
Journal:  Oxid Med Cell Longev       Date:  2021-05-12       Impact factor: 6.543

4.  Effects of dihydroartemisinin, a metabolite of artemisinin, on colon cancer chemoprevention and adaptive immune regulation.

Authors:  Chong-Zhi Wang; Chunping Wan; Yun Luo; Chun-Feng Zhang; Qi-Hui Zhang; Lina Chen; Zhi Liu; Daniel H Wang; Mallory Lager; Cang-Hai Li; Ting-Liang Jiang; Lifei Hou; Chun-Su Yuan
Journal:  Mol Biol Rep       Date:  2022-01-18       Impact factor: 2.316

Review 5.  Effectiveness of Complementary Therapies in Cancer Patients: A Systematic Review.

Authors:  María Dolores Guerra-Martín; María Sandra Tejedor-Bueno; Matías Correa-Casado
Journal:  Int J Environ Res Public Health       Date:  2021-01-24       Impact factor: 3.390

Review 6.  Chinese Medicine as an Adjunctive Treatment for Gastric Cancer: Methodological Investigation of meta-Analyses and Evidence Map.

Authors:  Cuncun Lu; Lixin Ke; Jieyun Li; Shuilin Wu; Lufang Feng; Youyou Wang; Alexios Fotios A Mentis; Peng Xu; Xiaoxiao Zhao; Kehu Yang
Journal:  Front Pharmacol       Date:  2022-01-10       Impact factor: 5.810

Review 7.  State of the Art and Future Implications of SH003: Acting as a Therapeutic Anticancer Agent.

Authors:  Kangwook Lee; Bo-Young Youn; Yu-Jeong Choi; Seunghwan Moon; Jungkwun Im; Kyongha Cho; Seong-Gyu Ko; Chunhoo Cheon
Journal:  Cancers (Basel)       Date:  2022-02-21       Impact factor: 6.639

8.  Molecular Assessment of Scutellaria barbata D. Don in the Treatment of Nasopharyngeal Carcinoma Based on Network Pharmacology and Experimental Verification.

Authors:  Hongjian Shi; Jie Liu; Jingying Fan; Lan He; Xianwen Wang; Faqing Tang; Daofa Tian; Yingchun He
Journal:  Evid Based Complement Alternat Med       Date:  2022-02-07       Impact factor: 2.629

9.  Anticancer Action of Xiaoxianxiong Tang in Non-Small Cell Lung Cancer by Pharmacological Analysis and Experimental Validation.

Authors:  Rongzhen Ding; Lijing Jiao; Shuliu Sang; Yinan Yin; Yichao Wang; Yabin Gong; Ling Xu; Ling Bi
Journal:  Evid Based Complement Alternat Med       Date:  2021-12-13       Impact factor: 2.629

Review 10.  Effectiveness and Safety of Chinese Medicine Decoctions for Behcet's Disease: A Systematic Review and Meta-Analysis.

Authors:  Jingxian Yan; Yi Yan; Andrew Young; Zhiyong Yan; Zhimin Yan
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-17       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.